Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 346-351

  Elsenberg, E H A M ^a   Sels, J E M ^b   Hillaert, M A ^a   Schoneveld, A H ^a   Van Den Dungen, N A M ^a   Van Holten, T C ^a   Roest, M ^a   Jukema, J W ^c   Van Zonneveld, A J ^c   De Groot, P G ^a   Pijls, N ^b   Pasterkamp, G ^a   Hoefer, I E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Circulating cells; Coronary artery disease; Cytokines; Toll like receptor response

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; P 3C 500; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS;

ATHEROSCLEROSIS; CIRCULATING CELLS; CORONARY ARTERY DISEASE; CYTOKINES; TOLL-LIKE RECEPTOR RESPONSE;

AGED; ANGINA, STABLE; ANTIGENS, CD11B; AREA UNDER CURVE; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; RISK FACTORS; TOLL-LIKE RECEPTORS;

EID: 84888092224     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.036     Document Type: Article

References (32)

1. Ross R. Atherosclerosis-an inflammatory disease. NEngl J Med 1999, 340(2):115-126.
2. Lundberg A.M., Hansson G.K. Innate immune signals in atherosclerosis. Clin Immunol 2010, 134(1):5-24.
3. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86(2):515-581.
4. Ait-Oufella H., Taleb S., Mallat Z., et al. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31(5):969-979.
5. Boekholdt S.M., Peters R.J., Hack C.E., et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004, 24(8):1503-1508.
6. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5(4):e78.
7. Gotsman I., Stabholz A., Planer D., et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?. Isr Med Assoc J 2008, 10(7):494-498.
8. Inoue T., Komoda H., Nonaka M., et al. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 2008, 124(3):319-325.
9. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101(15):1767-1772.
10. Cole J.E., Georgiou E., Monaco C. The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm 2010, 2010:1-18.
11. Hodgkinson C.P., Ye S. Toll-like receptors, their ligands, and atherosclerosis. ScientificWorldJournal 2011, 11:437-453.
12. Edfeldt K., Swedenborg J., Hansson G.K., et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002, 105(10):1158-1161.
13. Ishikawa Y., Satoh M., Itoh T., et al. Local expression of toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) 2008, 115(4):133.
14. Vink A., Schoneveld A.H., van der Meer J.J., et al. Invivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 2002, 106(15):1985-1990.
15. Methe H., Kim J.O., Kofler S., et al. Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 2005, 111(20):2654-2661.
16. Ashida K., Miyazaki K., Takayama E., et al. Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease. JAtheroscler Thromb 2005, 12(1):53-60.
17. Mizoguchi E., Orihara K., Hamasaki S., et al. Association between toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina. Coron Artery Dis 2007, 18(1):31-38.
18. Kuwahata S., Fujita S., Orihara K., et al. High expression level of toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease. Atherosclerosis 2010, 209(1):248-254.
19. Versteeg D., Hoefer I.E., Schoneveld A.H., et al. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve. Heart 2008, 94(6):770-776.
20. Hoefer I.E., Sels J.-W., Jukema J.W., et al. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol 2013 Aug 28, [E-pub ahead of print]. 10.1007/s00392-013-0607-9.
21. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. NEngl J Med 2008, 359(21):2195-2207.
22. Wilson P.W.F., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
23. Krysiak R., Okopień B. Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure. Pharmacol Rep 2012, 64(6):1466-1475.
24. Ferrario C.M., Strawn W.B. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006, 98(1):121-128.
25. Ridker P.M., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. NEngl J Med 2002, 347(20):1557-1565.
26. Wilson P.W., Nam B.H., Pencina M., et al. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005, 165(21):2473-2478.
27. Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108(16):1930-1932.
28. Castell J.V., Gomez-Lechon M.J., David M., et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989, 242(2):237-239.
29. Liu N., Liu J., Ji Y., et al. C-Reactive protein induces TNF-α secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells. Inflammation 2010, 34(4):283-290.
30. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., et al. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. JLeukoc Biol 1993, 53(4):439-445.
31. Liuzzo G., Angiolillo D.J., Buffon A., et al. Enhanced response of blood monocytes to invitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001, 103(18):2236-2241.
32. Satoh M., Shimoda Y., Maesawa C., et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006, 109(2):226-234.